How do you pay?

How to pay the least

Lowest posted price

from $90 for 30 g

Tri-Luma from Galderma, without insurance.

  1. Sign up for Galderma CAREConnect Patient Savings Card. Or call 1-855-636-5884.Sign up on galdermacc.com 

No generic is sold yet.

Compare every option

Question
Brand nameTri-Luma
Authorized genericfluocinolone acetonide, hydroquinone, and tretinoin
Regular genericfluocinolone acetonide, hydroquinone, and tretinoin
What you’d pay
From$90for 30 g with the maker’s card
Not soldThere isn’t one
Not soldNone sold yet
Same as Tri-Luma?
The original
–
–

Brand nameThe maker’s card

Galderma CAREConnect Patient Savings Card

Savings card from Galderma

No insurance · from $90 for 30 g
Insurance · as little as $20 for 30 g

Sign up on galdermacc.com 

Or call 1-855-636-5884.

In the maker’s words

“TRI-LUMA® (fluocinolone acetonide 0.01%, 30 g $20 $90 hydroquinone 4%, tretinoin 0.05%) Cream…”

From the maker’s offer on galdermacc.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Tri-Luma itself, from the same company, sold without the brand name, and usually for less. For now Tri-Luma is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TRI-LUMA Cream is a combination of fluocinolone acetonide (a corticosteroid), hydroquinone (a melanin synthesis inhibitor), and tretinoin (a retinoid) that is indicated for the short-term treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.

Source: the FDA label for Tri-Luma (Galderma Laboratories, L.P.), October 24, 2024. Full label on DailyMed 

Good to know